704 articles in this topic
A surprise immune cell steps in when the expected one is absent, keeping mRNA cancer vaccines effective and opening new design possibilities.
Johns Hopkins scientists reveal how fetal cone cells transform under vitamin A signals, opening doors to vision-restoring therapies.
A completed NCI phase II trial examines whether adding bevacizumab and/or carboplatin to standard paclitaxel shrinks operable breast tumors before surgery.
A JAMA review article on the relationship between obesity and cancer. Only title and metadata were available for this summary.
Obesity and aging combine to elevate a gut microbe inside breast tissue, triggering oxidative stress that fuels tumor growth.
A liposomal KRAS-G12D inhibitor combined with chemotherapy met its primary endpoint in a phase 1b/2 trial for advanced pancreatic cancer.
UCLA researchers find creatine energizes dendritic cells, potentially boosting immunotherapy success rates beyond the current 20-40% threshold.
Researchers decoded how bacteria naturally build multiple cancer drug variants, unlocking a blueprint for faster, more targeted therapies.
Cornell-engineered C' dots triggered tumor self-destruction and flipped immune resistance, producing complete remissions when paired with immunotherapy.
A landmark JAMA study finds lung transplant dramatically outperforms medical management for select stage IV NSCLC patients with respiratory failure.
A bacterial peptide called aurB targets mitochondria in cancer cells, cutting off their energy supply in preclinical prostate cancer studies.
New commentary explores how to manage isolated brain progression in extensive-stage small cell lung cancer without abandoning effective systemic treatment.
